Form 4 for CYRX Cryoport, Inc.
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-18 · accession 0001104659-24-121156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-20 | 2024-11-18+ | CYRX | SHELTON JERRELL | Pres, CEO, Dir | S - Sale+OE | $6.72 | -150.0K | 712.7K | -17% | -$1.01M |
| DM | 2024-11-20 | 2024-11-18+ | CYRX | SHELTON JERRELL | Pres, CEO, Dir | M - OptEx | $4.80 | +180.7K | 762.7K | +31% | +$867.1K |
| DM | 2024-11-20 | 2024-11-18+ | CYRX | SHELTON JERRELL | Pres, CEO, Dir | M - OptEx | $0.00 | -180.7K | 86.0K | -68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-18 | S | D | 50,000 | $6.73 | 702,307 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.94, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-11-20 | S | D | 50,000 | $6.65 | 722,747 | D | — | — | (F4) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.47 to $6.93, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-11-19 | S | D | 50,000 | $6.78 | 712,747 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.48 to $6.935, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2024-11-20 | M | A | 60,000 | $4.80 | 772,747 | D | — | — | |
| 5 | Common | Common Stock | 2024-11-18 | M | A | 60,215 | $4.80 | 752,307 | D | — | — | |
| 6 | Common | Common Stock | 2024-11-19 | M | A | 60,440 | $4.80 | 762,747 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2024-11-18 | M | D | 60,215 | $0.00 | 206,452 | D | $4.80 · — to 2024-12-18 | 60,215 Common Stock | (F5) 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. |
| 8 | Derivative | Stock Option (right to buy) | 2024-11-19 | M | D | 60,440 | $0.00 | 146,012 | D | $4.80 · — to 2024-12-18 | 60,440 Common Stock | (F5) 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. |
| 9 | Derivative | Stock Option (right to buy) | 2024-11-20 | M | D | 60,000 | $0.00 | 86,012 | D | $4.80 · — to 2024-12-18 | 60,000 Common Stock | (F5) 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. |